Another Round Of Layoffs Underway At Sage, Including Half Of R&D
The latest reorganization comes after a mid-stage pipeline asset failed in Alzheimer’s disease and Parkinson’s disease.
The latest reorganization comes after a mid-stage pipeline asset failed in Alzheimer’s disease and Parkinson’s disease.